Total Payments
$10,593
2024 Payments
$1,869
Companies
57
Transactions
600
Medicare Patients
413
Medicare Billing
$43,811
Payment Breakdown by Category
Food & Beverage$10,589 (100.0%)
Education$4.54 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,589 | 599 | 100.0% |
| Education | $4.54 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,459 | 102 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $982.00 | 58 | $0 (2024) |
| PFIZER INC. | $802.51 | 48 | $0 (2024) |
| Lilly USA, LLC | $720.95 | 47 | $0 (2024) |
| Novo Nordisk Inc | $585.47 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $531.60 | 25 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $527.40 | 26 | $0 (2024) |
| Amarin Pharma Inc. | $436.27 | 23 | $0 (2021) |
| Nestle HealthCare Nutrition Inc. | $389.19 | 19 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $330.48 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,869 | 94 | ABBVIE INC. ($463.28) |
| 2023 | $1,624 | 89 | AbbVie Inc. ($342.46) |
| 2022 | $1,619 | 106 | ABBVIE INC. ($268.78) |
| 2021 | $1,690 | 100 | AbbVie Inc. ($306.94) |
| 2020 | $1,598 | 83 | Amarin Pharma Inc. ($399.68) |
| 2019 | $656.39 | 36 | PFIZER INC. ($136.84) |
| 2018 | $770.27 | 44 | PFIZER INC. ($187.61) |
| 2017 | $766.03 | 48 | Janssen Pharmaceuticals, Inc ($115.53) |
All Payment Transactions
600 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Obesity | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Oncology | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 77 | 169 | $19,905 | $8,003 |
| 2022 | 9 | 159 | 339 | $39,839 | $15,670 |
| 2021 | 5 | 97 | 224 | $28,695 | $12,198 |
| 2020 | 5 | 80 | 189 | $24,739 | $7,940 |
Total Patients
413
Total Services
921
Medicare Billing
$43,811
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 38 | $7,600 | $3,303 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 51 | $6,630 | $3,051 | 46.0% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2023 | 15 | 39 | $4,290 | $1,295 | 30.2% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 11 | 15 | $1,125 | $298.88 | 26.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 11 | 26 | $260.00 | $54.74 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 90 | $11,700 | $5,368 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 51 | $10,200 | $4,508 | 44.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 14 | 37 | $4,995 | $1,598 | 32.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 13 | 36 | $4,140 | $1,389 | 33.6% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2022 | 13 | 44 | $4,840 | $1,293 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 26 | $2,210 | $1,015 | 45.9% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2022 | 13 | 18 | $1,350 | $413.24 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 17 | $204.00 | $50.31 | 24.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 11 | 20 | $200.00 | $35.28 | 17.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 49 | $9,800 | $4,802 | 49.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 65 | $8,450 | $3,882 | 45.9% |
| 98926 | Osteopathic manipulative treatment to 3-4 body regions | Office | 2021 | 19 | 55 | $6,050 | $1,851 | 30.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 27 | $2,295 | $1,068 | 46.5% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2021 | 17 | 28 | $2,100 | $596.88 | 28.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 90 | $13,592 | $4,433 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 28 | $5,673 | $1,987 | 35.0% |
| 98926 | Osteopathic manipulative treatment to 3-4 body regions | Office | 2020 | 16 | 39 | $4,271 | $1,192 | 27.9% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2020 | 12 | 14 | $1,059 | $296.76 | 28.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 11 | 18 | $144.54 | $32.28 | 22.3% |
About Dr. Marcus Cornwall, D.O
Dr. Marcus Cornwall, D.O is a Family Medicine healthcare provider based in Milwaukie, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689639841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Cornwall, D.O has received a total of $10,593 in payments from pharmaceutical and medical device companies, with $1,869 received in 2024. These payments were reported across 600 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($10,589).
As a Medicare-enrolled provider, Cornwall has provided services to 413 Medicare beneficiaries, totaling 921 services with total Medicare billing of $43,811. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Milwaukie, OR
- Active Since 04/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689639841
Products in Payments
- UBRELVY (Drug) $594.56
- ZENPEP (Drug) $572.53
- REXULTI (Drug) $539.52
- QULIPTA (Drug) $451.30
- CHANTIX (Drug) $449.38
- Vascepa (Drug) $436.27
- FARXIGA (Drug) $419.53
- JARDIANCE (Drug) $401.30
- Kerendia (Drug) $330.48
- VRAYLAR (Drug) $312.63
- Ozempic (Drug) $271.87
- TRULICITY (Drug) $266.91
- NURTEC ODT (Drug) $264.27
- BREZTRI (Drug) $221.14
- Otezla (Drug) $195.95
- TRADJENTA (Drug) $193.79
- MOUNJARO (Drug) $186.37
- Trintellix (Drug) $185.01
- Wegovy (Drug) $136.96
- BELSOMRA (Drug) $129.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Milwaukie
Ansab Khwaja, Md Pc, MD PC
Family Medicine — Payments: $12,884
Family Medicine $12,884
Johanna Warren, Md, MD
Family Medicine — Payments: $6,658
Family Medicine $6,658
Patrick Erickson, Do, DO
Family Medicine — Payments: $4,710
Family Medicine $4,710
Edward Lin, D.o, D.O
Family Medicine — Payments: $3,426
Family Medicine $3,426
Dr. Jerrold Snow, Do, DO
Family Medicine — Payments: $594.78
Family Medicine $594.78
Joshua Reagan, Md, MD
Family Medicine — Payments: $109.31
Family Medicine $109.31